MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $875,000 | -36.8% | 30,097 | 0.0% | 0.99% | -26.3% |
| Q3 2018 | $1,384,000 | +23.0% | 30,097 | 0.0% | 1.35% | +23.6% |
| Q2 2018 | $1,125,000 | +26.5% | 30,097 | 0.0% | 1.09% | +23.8% |
| Q1 2018 | $889,000 | -82.0% | 30,097 | -79.1% | 0.88% | -81.9% |
| Q4 2017 | $4,949,000 | -0.2% | 144,097 | +5.1% | 4.88% | -13.9% |
| Q3 2017 | $4,961,000 | +22.2% | 137,111 | -12.7% | 5.67% | +21.3% |
| Q2 2017 | $4,060,000 | +34.6% | 157,111 | 0.0% | 4.67% | +41.2% |
| Q1 2017 | $3,017,000 | +33.1% | 157,111 | +15.6% | 3.31% | +31.5% |
| Q4 2016 | $2,266,000 | +15.3% | 135,911 | +42.3% | 2.52% | +19.0% |
| Q3 2016 | $1,966,000 | -25.7% | 95,511 | +22.7% | 2.11% | -16.9% |
| Q2 2015 | $2,645,000 | -4.0% | 77,810 | 0.0% | 2.54% | +3.3% |
| Q1 2015 | $2,754,000 | +3.9% | 77,810 | 0.0% | 2.46% | -5.4% |
| Q4 2014 | $2,650,000 | – | 77,810 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |